Clinical Trial

Liver Metabolic Functions in Patients With Citrin Deficiency and Healthy Subjects

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Citrin is an aspartate-glutamate transporter in the liver that facilitates the urea cycle pathway for ammonia detoxification via ureagenesis. It is also thought to be involved in liver energy metabolism as a component of the malate-aspartate shuttle. The clinical presentation in patients supports the hypothesis that liver glycolytic, gluconeogenic and lipogenic functions are compromised in citrin deficiency, but none of the key hepatic pathway fluxes have been measured in patients to date. This is the first study that will examine the liver metabolic fluxes in patients with citrin deficiency. Liver metabolic functions will be examined by metabolic flux assays and biochemical measurements after application of stable isotopes 2H2O and \[U-13C6\]-fructose. Urea cycle metabolites and their enrichment after application of a stable isotope tracer 15NH4Cl will be measured to examine the liver's ability to detoxify ammonia into urea.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-03; most recent amendment 2026-01-05.
Status change: Recruiting → Active, Not Recruiting 2026-01-05
Status change: Not Yet Recruiting → Recruiting 2025-09-12
Trial Details
NCT Number NCT07055269
Lead Sponsor Johannes Haeberle
Collaborators: Citrin Foundation, Marc Hellerstein, University of Berkeley
Conditions Citrin Deficiency
Enrollment 20 participants
Start Date 2025-10-20
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-08